U.S. Online Retail and Ecommerce Stock News

Recent Performance Snapshot for UGI Stock UGI (UGI) has drawn attention after a mixed period for its stock, with the price recently closing at $34.72. Short term returns were positive, although the share price was down over the past month and over the past three months. See our latest analysis for UGI. Looking beyond the latest move, UGI stock shows short term share price momentum that has recently softened, with the year to date share price return down 7.73% while the 3 year total...

Lumentum Holdings (NasdaqGS:LITE) highlighted an AI-focused optics backlog exceeding $400 million at a recent global conference on AI ethics and governance. Leadership outlined how optical circuit switches and co packaged optics are positioned within AI data center infrastructure build outs. The company also discussed AI data center partnerships, emphasizing collaboration with large scale customers and ecosystem players. These comments add fresh detail on Lumentum Holdings' role in AI...

FedEx reported its fiscal fourth-quarter and full-year 2026 results, with Q4 revenue rising to US$25,007 million while net income slipped to US$1,598 million, and full-year revenue increasing to US$94,720 million alongside higher annual earnings per share from continuing operations of US$18.55. The company also completed the spin-off of FedEx Freight, raised its annual dividend by 5%, and issued new guidance calling for around 11% revenue growth and diluted EPS of US$16.55 to US$17.75 for...

On 23 June 2026, TD Cowen analyst Kyle Boucher reiterated a positive view on Bio-Techne, describing it as a premier small to mid-cap option despite ongoing life sciences market softness and recent insider selling. His comments, alongside a broader consensus that still sees moderate upside for the company despite funding and demand headwinds, suggest investors are reassessing how Bio-Techne is valued within a challenged sector. Next, we'll examine how this renewed analyst confidence, despite...

BridgeBio Pharma stock performance snapshot BridgeBio Pharma (BBIO) trades at $68.63 after a mixed recent performance, with gains over the past week but declines over the month and past 3 months, while its 1 year total return remains positive. Investors watching BridgeBio Pharma may also note annual revenue of $579.96 million alongside a reported net loss of $721.55 million. This highlights an active development pipeline that is not yet translating into positive earnings. See our latest...

Infleqtion stock moves after recent performance swing Infleqtion (INFQ) has drawn attention after a sharp move in its stock, with a 12.3% gain over the past day and a 19.3% rise across the past week prompting closer investor scrutiny. See our latest analysis for Infleqtion. Set against a year-to-date share price return that is down 6.9%, the recent 40.9% 90-day share price return suggests momentum in Infleqtion is building again as investors reassess its quantum computing potential and risk...

At its Pure//Accelerate 2026 event earlier this month, Veeam Software and Everpure expanded their global alliance and unveiled new integrated cyber resilience, DataAI Resilience, and Kubernetes protection capabilities across Everpure’s Enterprise Data Cloud and Portworx stack. Together with Everpure’s new Data Stream and Data Intelligence offerings, these moves push the company further toward a data-centric AI infrastructure role that tightly couples storage, governance, and cyber resilience...

MoonLake Immunotherapeutics (MLTX) has become a focus for many investors after strong one-year Phase 3 VELA data for sonelokimab in hidradenitis suppurativa and a planned Biologics License Application filing by the end of September. See our latest analysis for MoonLake Immunotherapeutics. That clinical update has come alongside a sharp move in MoonLake Immunotherapeutics’ share price, with a 7-day share price return of 11.80% and a 30-day share price return of 16.66%. However, the 1-year...

Cencora (NYSE:COR) has launched a multi site pilot of its enhanced Nucleus inventory management solution for specialty physician practices. The company also announced an executive transition in the Chief Human Resources Officer role, bringing in a CHRO from another large corporation. Cencora is drawing attention with these linked operational and leadership moves, as investors weigh what they might mean for the business. The stock recently closed at $281.1, with a value score of 6 and long...

U.S. Supreme Court rules 6-3 in favor of Exxon Mobil (NYSE:XOM) in a case involving Cuban state-owned companies. Decision revives Exxon's claim for more than US$1b in damages tied to assets seized in Cuba decades ago. Ruling finds that foreign sovereign immunity does not shield the Cuban entities in this dispute. Outcome may influence how other U.S. companies pursue claims over expropriated property abroad. Exxon Mobil is one of the largest integrated energy companies, with operations that...

American Tower (NYSE:AMT) is expanding its data center operations as demand tied to AI workloads and multicloud deployments increases. The company is emphasizing its role in digital infrastructure that supports cloud computing alongside its traditional tower leasing business. This shift highlights how AI and cloud trends are influencing American Tower's mix of assets and services. For investors used to thinking of American Tower mainly as a tower landlord, the growing focus on data centers...

Quantum Computing Inc. (NasdaqCM:QUBT) has completed its acquisition of NHanced Semiconductors. The deal brings NHanced in as a wholly owned subsidiary of Quantum Computing Inc. The company has launched Fab 2 to support commercial quantum and photonic hardware production. For Quantum Computing Inc., this acquisition is a significant move into chip manufacturing and advanced packaging, which sit at the heart of quantum and photonic hardware. As more computing workloads push into areas like...

Definium Therapeutics (NasdaqGS:DFTX) reported positive topline Phase 3 results for DT120 in major depressive disorder. The company completed a US$700 million follow on equity offering to fund regulatory and commercialization plans for DT120. The latest data readout and capital raise were announced together as Definium Therapeutics positions DT120 for potential market entry. Definium Therapeutics focuses on treatments for psychiatric conditions, with DT120 targeting major depressive...

CRH stock snapshot and recent returns CRH (NYSE:CRH) has drawn investor interest after a mixed run in its share price, with the stock down about 0.9% on the day and 2.3% over the past week. Over the past month, CRH has gained roughly 9.9%, while its total return over the past 3 months is about 4%. Year to date, the stock is down around 12.8%, yet its 1 year total return stands near 21.9%. See our latest analysis for CRH. CRH’s recent pullback in its share price, with a year to date share...

Stabilizing same store sales put Chipotle Mexican Grill (CMG) back in focus Chipotle Mexican Grill (CMG) is back on investor radars after its first quarter 2026 update showed same store sales edging up 0.5%, a shift from the declines that weighed on the stock in 2025. See our latest analysis for Chipotle Mexican Grill. Despite the improvement in same store sales, Chipotle Mexican Grill's share price has had a tougher run, with the 1 year total shareholder return down 43.37% and the year to...

Interest in MPLX (MPLX) has picked up after the stock outpaced major indices in the latest session, with attention now turning to its August 4, 2026 earnings report and expectations for earnings and revenue performance. See our latest analysis for MPLX. At a share price of $57.68, MPLX has seen short term share price momentum with a 1 day share price return of 1.37% and a 7 day share price return of 2.85%. The 1 year total shareholder return of 20.36% and 5 year total shareholder return of...

If you are wondering whether Amkor Technology stock still offers value after a strong run, this article breaks down what the current price might be implying about the company. At a last close of US$86.72, Amkor Technology has posted returns of 0.2% over 7 days, 31.9% over 30 days, 102.1% year to date and 317.3% over the past year, so it is understandable that investors are rechecking the valuation. Recent attention on Amkor Technology has been driven by its share price performance across...

Over the last 7 days, the United States market has experienced a 2.3% decline, yet it remains up by 21% over the past year with earnings forecasted to grow annually by 19%. In this context of fluctuating market conditions, identifying promising small-cap stocks with notable insider activity can offer intriguing opportunities for investors seeking potential value.

Over the last 7 days, the United States market has experienced a 2.3% decline, yet it remains up by 21% over the past year with earnings projected to grow by 19% annually in the coming years. In this context, identifying high growth tech stocks involves looking for companies with strong innovation and scalability potential that can thrive despite short-term market fluctuations.

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 21% over the past year, with earnings forecasted to grow by 19% annually. In this context, identifying stocks that may be trading below their fair value can present opportunities for investors seeking to capitalize on potential growth and resilience in a fluctuating market environment.

From what we can see, insiders were net buyers in System1, Inc.'s ( NYSE:SST ) during the past 12 months. That is...

Over the last 7 days, the United States market has experienced a 2.3% decline, yet it remains up by 21% over the past year with earnings forecasted to grow by 19% annually. In this context of fluctuating market conditions, companies with high insider ownership can often signal strong confidence in future growth prospects, making them appealing considerations for investors seeking robust opportunities.

Over the last 7 days, the U.S. market has dropped 2.3%, but it is up 21% over the past year with earnings forecasted to grow by 19% annually. In light of these conditions, identifying stocks with strong fundamentals and growth potential can be key to navigating market fluctuations. Penny stocks, though an older term, still represent a viable investment area; they often involve smaller or newer companies that offer unique growth opportunities at lower price points.

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains robust with a 21% increase over the past year and an earnings forecast predicting a 19% annual growth. In this dynamic environment, identifying lesser-known stocks with strong fundamentals and growth potential can offer unique opportunities for investors seeking to capitalize on these positive trends.